首页> 美国卫生研究院文献>World Journal of Gastroenterology >Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles
【2h】

Study on the anticarcinogenic effect and acute toxicity of liver-targeting mitoxantrone nanoparticles

机译:靶向肝的米托蒽醌纳米颗粒的抗癌作用和急性毒性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To study the anticarcinogenic effect and acute toxicity of liver targeting mitoxantrone-nanospheres.METHODS: The anticarcinogenic effect of mitoxantrone-polybutyl cyanoacrylate-nanoparticles ( DHAQ-PBCA-NP ) was investigated by using heterotopic and orthotopic transplantation models of human hepatocellular carcinoma ( HCC ) in nude mice and was compared with mitoxantrone (DHAQ) and doxorubicin (ADR). The acute toxicity of DHAQ-PBCA-NP lyophilized injection in mice was also studied.RESULTS: The tumor inhibition rates of ADR, DHAQ, DHAQ-PBCA-NP to orthotopically transplanted HCC were 60.07%, 67.49% and 99.44%, respectively, but regard to heterotopically transplanted HCC, these were 80.03%, 86.18% and 92.90%, which were concordant with the results acquired by mitosis counting and proliferating cell nuclear antigen (PCNA). After iv administration to mice with DHAQ-PBCA-NP, the LD50 was 16.9 mg/kg ± 3.9 mg/kg, no obvious local irritation was observed and there was no significant damage to the structure of liver cells, and that of the heart, spleen and kidneys.CONCLUSION: The effect of DHAQ-PBCA-NP was significantly higher than that of DHAQ and ADR in the anti-orthotopically transplanted HCC and the acute toxicity was relatively low.
机译:目的:研究针对肝癌的米托蒽醌-纳米球的抗癌作用和急性毒性。方法:采用异位和原位肝移植模型,研究米托蒽醌-聚氰基丙烯酸丁酯-纳米颗粒(DHAQ-PBCA-NP)的抗癌作用。 HCC)与裸鼠米托蒽醌(DHAQ)和阿霉素(ADR)进行比较。结果:ADR,DHAQ,DHAQ-PBCA-NP对原位移植肝癌的抑瘤率分别为60.07%,67.49%和99.44%。异位移植肝癌的发生率分别为80.03%,86.18%和92.90%,这与有丝分裂计数和增殖细胞核抗原(PCNA)获得的结果一致。静脉注射DHAQ-PBCA-NP小鼠后,LD50为16.9 mg / kg±3.9 mg / kg,未观察到明显的局部刺激,并且对肝细胞和心脏的结构均无明显损害,结论:DHAQ-PBCA-NP在原位移植肝癌中的作用明显高于DHAQ和ADR,急性毒性较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号